Minor Use Minor Species Development of Drugs (R01)
Offen
Food and Drug Administration plant Förderungen mit bis zu 250.000 $ pro Projekt bei einem Gesamtbudget von 250.000 $. Die Einreichungsfrist endet am 29. Januar 2027. Antragsberechtigte Gruppen laut Quelle: Small businesses, Independent school districts, Special district governments und 12 weitere.
Frist
29. Januar 2027 (in 75 Tagen)
Fördersumme
bis zu 250.000 $ pro Projekt
Förderquote
Kein Pflicht-Eigenanteil angegeben; Förderquote nicht angegeben
Gesamtbudget
250.000 $
Eigenanteil
Nicht erforderlich
Wahrscheinliche Antragstellende
KMU / Start-ups, Unternehmen, Öffentliche Stellen, Hochschulen & Forschung, Gemeinnützige Aus Quellkategorien oder Programmregeln; maßgeblich ist die Ausschreibung.
Die offiziellen Beschreibungen sind in der Sprache des Fördergebers (meist Englisch); Zusammenfassung und Eckdaten auf dieser Seite sind auf Deutsch.
Über diese Ausschreibung
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS).
The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.
Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.
The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.
Vollständigen Text lesen
FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.
Wer kann sich bewerben?
Small businesses
Independent school districts
Special district governments
Public housing authorities/Indian housing authorities
Private institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
State governments
Native American tribal governments (Federally recognized)
County governments
City or township governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 13. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare d…
The purpose of this Notice of Funding Opportunity (NOFO) is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change…
The Applied Mathematics program supports mathematics research motivated by and contributing to the solution of problems arising in science and engineering. Successful pro…
The Astronomy and Astrophysics Research Grants (AAG) Program is an inclusive and flexible funding opportunity to support research in the astronomical sciences. The Progra…
Defense Health Agency Contracting Activity - DHACAUSA
Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fu…